ArticleCancer medicine2019

A new risk score for patients after first recurrence of stage 4 neuroblastoma aged ≥18 months at first diagnosis.

Kiana Kreitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.